Comparison of intravenous infusion of propofol and sodium valproate on alleviation of acute migraine
Not Applicable
- Conditions
- Migraine Headache.Migraine
- Registration Number
- IRCT2012121911822N1
- Lead Sponsor
- Vice chancellor of Research and Technology, Hamadan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Acute migraine attack; 20 to 50 years; ASA=II
Exclusion criteria: Patient refuse; Allergy to propofol or sodium valproate; Allergy to egg or soya
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Headache severity. Timepoint: Before administration of drugs and each 15 min during drug infusion and each 30 min for two hours. Also, in patient with reduced severity of pain we will assist pain severity for next 24 and 48 hours. Method of measurement: Numerical Rating Scale (NRS), 0 for without pain and 10 for worst pain.
- Secondary Outcome Measures
Name Time Method Any side effect such as allergy. Timepoint: Each 15 min during drug infusion and each 30 min for two hours. Also, in patient with reduced pain for next 24 and 48 hours through the telephone. Method of measurement: Ask from patient according to Questionnaire.